Volume 8, Number 2 (March/April 2010) |
Bench to Bedside |
52 |
|
Interventional Therapies for the Management of Cancer Pain
Shane Brogan, MB, BCh, and Scott Junkins, MD Interventional Pain Service, Huntsman Cancer Institute, and Department of Anesthesiology, University of Utah, Salt Lake City, Utah
|
|
|
PEER VIEWPOINTS
Interventional Procedures for Cancer Pain Management: Selecting the Right Procedure at the Right Time
Dermot Fitzgibbon, MD, Department of Anesthesiology and Pain Medicine and Department of Medicine, University of Washington School of Medicine, Seattle, Washington
|
|
|
Positioning of Interventional Pain Therapies Requires Balancing of Risks and Benefits and Consideration of Goals of Care
Ronald Kaplan, MD, Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, and Department of Anesthesiology, Albert Einstein College of Medicine, Bronx, New York
|
64 |
|
Addressing Low Literacy and Health Literacy in Clinical Oncology Practice
Sofia F. Garcia, PhD, Elizabeth A. Hahn, MA, and Elizabeth A. Jacobs, MD, MPP Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois; and Division of General Medicine and Primary Care, John H. Stroger Jr. Hospital of Cook County and Rush University Medical Center, Chicago, Illinois
|
|
|
PEER VIEWPOINT
Improving Response to Health Literacy
Chesley Cheatham, MEd, CHES, and Nita D. Pyle, MSN, RN, Patient Education Office, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
|
Original Research |
72 |
|
Managing Cetuximab Hypersensitivity-Infusion Reactions: Incidence, Risk Factors, Prevention, and Retreatment
Thomas J. George, Jr, MD, FACP, Kourtney D. LaPlant, PharmD, Edmund O. Walden, PharmD, BCOP, Arlene B. Davis, RN, MSN, AOCN, Charles E. Riggs, MD, Julia L. Close, MD, Sarah N. George, MA, and James W. Lynch, MD Division of Hematology/Oncology, Department of Medicine, University of Florida; the NF/SG VA Medical Center, Pharmacy Section; and the Department of Mathematics, Santa Fe College, Gainesville, Florida
|
78 |
|
The Impact of Implementing Referral Criteria on the Pattern of Referrals and Admissions to a Palliative Care Program in Saudi Arabia
Mohammad Z. Al-Shahri, MBChB, ABFM, FFCM, ABHPM, Mahmoud Y. Sroor, MD, and Samy A. Alsirafy, MBBCh, MSc, MD, ABHPM, Dip Pall Med Section of Palliative Care Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia; and the Palliative Care Medicine Unit, Kasr Al-Aini Center for Clinical Oncology and Nuclear Medicine, Kasr Al-Aini School of Medicine, Cairo University, Cairo, Egypt
|
Review |
82 |
|
About This Continuing Education Activity
|
84 |
|
Management of Venous Thromboembolism in Cancer: A Brief Review of Risk-Benefit Approaches and Guidelines’ Recommendations
Benjamin Djulbegovic, MD, PhD Center for Evidence-Based Medicine and Health Outcomes Research, University of South Florida, and the H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida
CME/CE A continuing education activity for physicians, nurses, and pharmacists provided by the Meniscus Educational Institute and Elsevier Oncology and supported by an educational grant from Eisai Corporation and sanofi-aventis U.S. |
|
How We Do It |
92 |
|
The Art of Reinfusing Intestinal Secretions
Carol Rees Parrish, MS, RD, and Beth Quatrara, RN, MSN, ACNS-BC Digestive Health Center of Excellence, University of Virginia Health System, Charlottesville, Virginia
|
Available only on www.SupportiveOncology.net |
Outcomes Research |
W1 |
|
Intervals from Symptom Onset to Radiation Treatment of Malignant Spinal Cord Compression:Quantification and Effect on Pretreatment Neurologic Outcome
Gunita Mitera, BSc, MRT (T), and Andrew Loblaw, MD Departments of Radiation Therapy and Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario
|
W6 |
|
Routine Use of Health-Related Quality-of-Life Information in Advanced Cancer Patients:A Randomized, Controlled Outcome Investigation
Pei Lin Lua, B.Pharm, PhD, Sam Salek, BSc, PhD, and Ilora G. Finlay, MD, FRCP, FRCGP Centre for Clinical and Quality-of-Life Studies, Faculty of Medicine and Health Sciences, Universiti Darul Iman Malaysia, Kampus Kota, Terengganu, Malaysia; Welsh School of Pharmacy Centre for Socioeconomic Research, Cardiff University, Cardiff, Wales, United Kingdom; and Cardiff University School of Medicine, Cardiff, Wales, United Kingdom
|
|
© 2010 Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without written permission from the publisher.
The opinions expressed herein are those of the authors or advertisers. The authors, editors, and publishers make every effort to ensure that no inaccurate or misleading data, opinion, or statement is published in this journal and that drug names, dosages, and recommendations are accurate. However, readers should confirm all dosage schedules against the manufacturer’s package information data. The Publisher, Editorial Board, and their employees accept no liability whatsoever for the consequences of any inaccurate or misleading data, opinion, or statement. |
215 kb